Kanagawa Cardiovascular and Respiratory Center; Respiratory Medicine

Kanagawa 236-0051

0 studies enrolling now · 3 studies all time

What they study most

Idiopathic Pulmonary Fibrosis, Non-Small Cell Lung Cancer, Non-Squamous Non-Small Cell Lung Cancer

Studies at this site

• A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed
• A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Completed
• A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) — Completed